comparemela.com

Latest Breaking News On - Research centre in bijnor - Page 1 : comparemela.com

Covid XBB 1 16 raising conjunctivitis risk in infants: Study

The study, led by Vipin M. Vashishtha, member of WHO s Vaccine Safety Net, is based on 25 children seen in OPD of a paediatric hospital in Uttar Pradesh

Uttar pradeshVipinm vashishthaResearch centre in bijnorSafety netMangla hospitalResearch centreCovid xbb 1 16

Covid-19 Omicron XBB 1 16 Variant Raising Conjunctivitis Risk In Infants: Study

The study reveals that respiratory symptoms are predominating in young infants, and the youngest case was a 13-day-old newborn baby.

Uttar pradeshVan kerkhoveMaria van kerkhoveVipinm vashishthaResearch centre in bijnorWorld health organizationVaccine safety netMangla hospitalResearch centreCovid 19 cases in indiaOmicron variantCovid in kidsCovid guidelines in indiaLatest covid newsCovid updateCovid cases

Indian study shows Covid XBB 1 16 raising conjunctivitis risk in infants

Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed

Uttar pradeshVipinm vashishthaResearch centre in bijnorSafety netMangla hospitalResearch centreCovid 19 countCovid deathsOvid 19 updatesCoronavirus death tollCoronavirus newsCoronavirus treatmentCoronavirus symptomsOvid 19 symptomsNews on coronavirusHealth news

Indian study shows Covid XBB 1 16 raising conjunctivitis risk in infants

Indian study shows Covid XBB 1 16 raising conjunctivitis risk in infants
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.

Uttar pradeshNew delhiVipinm vashishthaResearch centre in bijnorSafety netMangla hospitalResearch centre

Indian study shows Covid XBB 1 16 raising conjunctivitis risk in infants

New Delhi, April 22: Amid the recent rise in Covid-19 cases in India, driven by the subvariant of Omicron XBB.1.16, there has been an increase in risk of conjunctivitis among children aged below one-year, according to a study, not yet peer-reviewed.

Uttar pradeshNew delhiVipinm vashishthaTina dattaResearch centre in bijnorSafety netMangla hospitalResearch centre

vimarsana © 2020. All Rights Reserved.